Login / Signup

Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy.

Rory Michael ShallisDarko PucarSudhir PerincheriSteven D GoreStuart E SeropianNikolai A PodoltsevAmer M Zeidan
Published in: Annals of hematology (2021)
Keyphrases
  • acute myeloid leukemia
  • tyrosine kinase
  • dendritic cells
  • bone marrow
  • immune response